- Report
- October 2025
- 99 Pages
Kuwait
From €4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 91 Pages
Oman
From €4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 98 Pages
Saudi Arabia
From €4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 82 Pages
Bahrain
From €4248EUR$4,850USD£3,687GBP
- Report
- July 2025
- 82 Pages
From €3022EUR$3,450USD£2,623GBP
- Report
- July 2025
- 90 Pages
Japan
From €4861EUR$5,550USD£4,219GBP
- Report
- June 2025
- 76 Pages
From €3022EUR$3,450USD£2,623GBP
- Report
- June 2025
- 128 Pages
Canada
From €5251EUR$5,995USD£4,557GBP
- Report
- June 2025
- 126 Pages
Australia
From €5251EUR$5,995USD£4,557GBP
- Report
- June 2025
- 123 Pages
India
From €5251EUR$5,995USD£4,557GBP
- Report
- June 2025
- 134 Pages
South Korea
From €5251EUR$5,995USD£4,557GBP
- Report
- June 2025
- 123 Pages
Italy
From €5251EUR$5,995USD£4,557GBP
- Report
- June 2025
- 126 Pages
Germany
From €5251EUR$5,995USD£4,557GBP
- Report
- June 2025
- 126 Pages
France
From €5251EUR$5,995USD£4,557GBP
- Report
- June 2025
- 122 Pages
United Kingdom
From €5251EUR$5,995USD£4,557GBP
- Report
- June 2025
- 140 Pages
Japan
From €1576EUR$1,800USD£1,368GBP
- Report
- May 2025
- 80 Pages
From €2584EUR$2,950USD£2,242GBP
- Report
- April 2025
- 34 Pages
Canada
From €4375EUR$4,995USD£3,797GBP
- Report
- April 2025
- 35 Pages
Germany
From €4375EUR$4,995USD£3,797GBP
- Report
- April 2025
- 33 Pages
India
From €4375EUR$4,995USD£3,797GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more